Immediate Hypersensitivity Reactions Against Biologicals

In associate with Bioanalysis Zone, BioAgilytix’s Chief Scientific Advisor, Dr. Arno Kromminga, and Principal Investigator, Dr. Janett Schwarz, discuss the observation of drug-specific IgE antibodies, usually associated with a type I reaction. Because IgE are 2000-fold less prevalent than IgG antibodies, a very sensitive detection method is required. The ImmunoCAP® platform at BioAgilytix (NC, USA) provides an ideal and proven system to analyze IgE-mediated drug hypersensitivities.